Meda Tacks On U.S. Supplements As GSK Cleans Out Medicine Cabinet
This article was originally published in The Tan Sheet
Executive Summary
Meda Pharmaceuticals bolstered its recently established U.S. presence by acquiring three supplement brands from GlaxoSmithKline.
You may also be interested in...
Meda Pumps Up Iron With Feosol Relaunch, Revamps Neglected OTCs
Meda Consumer Healthcare is relaunching the Feosol iron supplement brand with three SKUs and aims to become the clear No. 1 brand in the category. Meda’s Swedish parent company prioritizes OTC growth through brand acquisitions and increased marketing resources.
Meda Pumps Up Iron With Feosol Relaunch, Revamps Neglected OTCs
Meda Consumer Healthcare is relaunching the Feosol iron supplement brand with three SKUs and aims to become the clear No. 1 brand in the category. Meda’s Swedish parent company prioritizes OTC growth through brand acquisitions and increased marketing resources.
Antula Acquisition Expands Meda's OTC Portfolio, Marketing Expertise
Meda's acquisition of fast-growing Swedish OTC firm Antula Healthcare brings on board "proven" marketing expertise to boost existing product sales, a well-established nonprescription drug portfolio and a prolific pipeline for long-term growth.